Objective To investigate the incidence and characteristics of breast cancer in transgender
people in the Netherlands compared with the general Dutch population. Design …

Male breast cancers are uncommon, as men account for less than 1 percent of all breast
carcinomas. Among the predisposing risk factors for male breast cancer, the following …

Precision oncology is based on deep knowledge of the molecular profile of tumors, allowing
for more accurate and personalized therapy for specific groups of patients who are different …

Male breast cancer (MBC) is a rare disease. Due to its rarity, treatment is still directed by
data mainly extrapolated from female breast cancer (FBC) treatment, despite the fact that it …

Background Male breast cancer is rare, as it represents less than 1% of all breast cancer
cases. In addition, male breast cancer appears to have a different biology than female breast …

Background Although marital status has been reported as a prognostic factor in different
cancer types, its prognostic effect on hormone receptor (HR) positive male breast cancer …

Background Lobular breast carcinoma (LBC) is considered an exceptionally rare disease in
men, including only 1% of all male breast malignancies. The majority of LBCs have negative …

Abstract Purpose Androgen Receptor (AR) positivity is often displayed in breast cancer and
especially in Male Breast Cancer (MBC), where it appears to be a heterogeneous feature …

Abstract Background Use of the Oncotype DX recurrence score (RS) has been widely
adopted in women with early-stage hormone receptor-positive (HR+), human epidermal …

Background Previous studies have explored surgery refusal among female breast cancer
patients. However, little attention has been given to other therapies in both females and …